DrugPatentWatch Database Preview

Horizon Pharma Company Profile

HORIZON PHARMA has two approved drugs.

There are seventeen US patents protecting HORIZON PHARMA drugs.

There are ninety-seven patent family members on HORIZON PHARMA drugs in thirty-seven countries and seven supplementary protection certificates in six countries.

International Patents:	97
US Patents:	17
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Horizon Pharma:	See patent lawsuits for Horizon Pharma

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Horizon Pharma Usa	RAYOS	prednisone	TABLET, DELAYED RELEASE;ORAL	202020-002	Jul 26, 2012	AB	RX	Yes	No	9,504,699	➤ Sign Up				➤ Sign Up
Horizon Pharma Usa	PROCYSBI	cysteamine bitartrate	CAPSULE, DELAYED RELEASE;ORAL	203389-002	Apr 30, 2013		RX	Yes	Yes	9,198,882*PED	➤ Sign Up			Y	➤ Sign Up
Horizon Pharma Usa	PROCYSBI	cysteamine bitartrate	CAPSULE, DELAYED RELEASE;ORAL	203389-002	Apr 30, 2013		RX	Yes	Yes	9,925,158	➤ Sign Up	Y	Y		➤ Sign Up
Horizon Pharma Usa	PROCYSBI	cysteamine bitartrate	CAPSULE, DELAYED RELEASE;ORAL	203389-001	Apr 30, 2013		RX	Yes	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	1 mg, 2 mg, and 5 mg	➤ Subscribe	2012-11-26

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	201600089	➤ Sign Up
Canada	2938644	➤ Sign Up
World Intellectual Property Organization (WIPO)	0054780	➤ Sign Up
Brazil	PI0717052	➤ Sign Up
Country	Patent Number	Estimated Expiration

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1919458	300649	Netherlands	➤ Sign Up	PRODUCT NAME: CYSTEAMINE; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130910
1919458	19/2014	Austria	➤ Sign Up	PRODUCT NAME: CYSTEAMIN; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130910
1919458	122014000023	Germany	➤ Sign Up	PRODUCT NAME: CYSTEAMIN ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/13/861 20130906
1919458	2014C/018	Belgium	➤ Sign Up	PRODUCT NAME: CYSTEAMINE; AUTHORISATION NUMBER AND DATE: EU/1/13/861 20130910
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.